“…PEA is member of the N-acylethanolamides (NAEs) family, characterized for inhibiting mechanisms of secondary injury (Ahmad et al, 2012a ). This pro-homeostatic mediator (Petrosino et al, 2010 ; Petrosino and Di Marzo, 2017 ) exerted neuroprotective effects when administered exogenously in models of brain injury and neurodegeneration (Herrera et al, 2016 ), including spinal cord injury (Genovese et al, 2008 ; Esposito et al, 2011 ), traumatic brain injury (Ahmad et al, 2012a ; Guida et al, 2017a ), stroke (Ahmad et al, 2012b ), Alzheimer's Disease (D'Agostino et al, 2012 ; Scuderi et al, 2014 ), and Parkinson's Disease (Esposito et al, 2012 ). These effects are apparently mediated by the nuclear Peroxisome Proliferator-Activated Receptor (PPAR)-α (Lo Verme et al, 2005 ).…”